The first Cochrane evaluation on this subject (Yelland 2004B) was executed to target entirely on prolotherapy injections, following an earlier Cochrane review of all injection therapies for reduced‐back pain (Nelemans 2003) in which the sole treatment method that confirmed significant, sustained reductions in pain and incapacity at six months https://proleviate.com/use-conolidine-for-back-pain/